Introducing Citeline’s Sitetrove Diversity Module, Combining Robust Clinical Investigator and Site Intelligence With Patient Demographics to Support the Diversification of Clinical Trials

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) — With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” Citeline’s new Sitetrove Diversity Module marries rob...

Telesis Bio to Present at SynBioBeta 2023

Highlighting application of the Molecular Biology Workstation to accelerating vaccine and biologics discovery SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions,...